Endocrinology, Vol 113, 1771-1780, Copyright © 1983 by Endocrine Society

ARTICLES

Ontogeny of mesenchymal androgen receptors in the embryonic mouse mammary gland

G Wasner, I Hennermann and K Kratochwil

We demonstrate the presence of a high affinity androgen-binding site in the embryonic mouse mammary gland, and describe its appearance and development from the initial formation of the gland bud (day 12) through the androgen-responsive stage (day 14) until term (day 19). Binding assays were done on entire organ rudiments exposed to the ligand [( 3H] testosterone, [3H]5 alpha-dihydrotestosterone, or [3H]methyltrienolone) in vitro, and receptor levels are expressed per gland. In competition experiments, the binding site shows a ligand specificity of a typical rodent androgen receptor. Scatchard analysis yielded a figure of 90-100 million binding sites for one 14-day gland, or approximately 30,000 per target cell. The apparent dissociation constant Kd for ligand binding by the intact tissue was between 0.55 and 0.75 X 10(-9) M. The first binding sites become detectable at the time of mammary bud formation (day 12); their number increases about 20- fold towards the responsive stage (day 14), and they persist at high levels at least until birth. The loss of androgen responsiveness on day 15 is neither accompanied by a loss of receptors nor by a change of their binding affinity.

This article has been cited by other articles:

				Y. Sajjad, S. Quenby, P. Nickson, D I. Lewis-Jones, and G. Vince Immunohistochemical localization of androgen receptors in the urogenital tracts of human embryos Reproduction, September 1, 2004; 128(3): 331 - 339. [Abstract] [Full Text] [PDF]

				C. J. Wolf, G. A. LeBlanc, J. S. Ostby, and L. E. Gray Jr. Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin Toxicol. Sci., May 1, 2000; 55(1): 152 - 161. [Abstract] [Full Text] [PDF]

				A. Sourla, C. Martel, C. Labrie, and F. Labrie Almost Exclusive Androgenic Action of Dehydroepiandrosterone in the Rat Mammary Gland Endocrinology, February 1, 1998; 139(2): 753 - 764. [Abstract] [Full Text] [PDF]